[PRESS RELEASE] MIAMI, FL — May 21, 2025 – Triple 5 Distribution, the team behind the headline-making The Pocket Dab device, is once again shaking up the concentrate space. Introducing the Numb THCa Live Rosin Syringe—a first-of-its-kind, precision-dose glass syringe pre-filled with 2 grams of premium THCa live rosin designed for clean, torchless, mess-free consumption.
Engineered for both cannabis connoisseurs and curious newcomers, The Numb Syringe puts full-spectrum potency and control in the palm of the user’s hand. Its press-to-dispense dosing and terpene-rich formulation make it a highly versatile format—ideal for topping off a preroll, infusing a bowl, adding to a blunt, or even enhancing edibles and beverages.
What Makes It Different:
● 2g of premium THCa live rosin blended by Triple 5
● Glass syringe with press-to-dose precision
● Torchless format – no rig, scoop, or mess
● Reusable, clean, and travel-friendly
● Loud, strain-specific terpene profiles
Launching in Three Loud Strains:
● Lemon Dog Sh*t (Hybrid)
● OG Kush (Indica)
● Blue Dream (Sativa)
"This isn’t just another extract—it’s a tool," says Eli Dadon, CEO of Triple 5.
“The Numb Syringe empowers users to take control of their experience with a format that’s clean, convenient, and delivers our signature terpene-heavy rosin with zero compromise.”
As concentrate consumers increasingly seek flexibility, discretion, and flavor, the Numb Syringe unlocks new ways to microdose, infuse, or dab without the learning curve.
Part of a Bigger Movement
The launch follows the massive reception of The Pocket Dab, another Triple 5 innovation that redefined how consumers access live rosin. With the Numb Syringe, the company doubles down on its commitment to practical, premium, and culturally relevant cannabis tech.
“We’re not here to imitate,” adds Dadon. “We’re here to lead.”
Dabbing Gains Momentum in the U.S.
Dabbing has become one of the fastest-growing methods of cannabis consumption in the U.S., particularly among younger adults. According to a 2022 CDC report, 28.4% of cannabis users aged 18–24 report dabbing, underscoring its rising cultural relevance. As more consumers move away from traditional smoking, the demand for potent, flavorful, and format-flexible extracts continues to grow—paving the way for innovations like The Numb Syringe.
For more information, click here.
